News | Mental health

Opinion

We cannot ignore race when it comes to pharmacogenomics

Research on pharmacogenomics must reflect diversity within populations to truly benefit patients.…

Published: 18 May 2022

News

NICE has ‘failed to listen to patient evidence’ on prescription drug withdrawal, claims parliamentary group

The All-Party Parliamentary Group for Prescribed Drug Dependence has criticised the National Institute for Health and Care Excellence on its new guidance on tapered withdrawal of dependency-forming drugs.…

Published: 21 April 2022

News

Antidepressants do not improve quality of life long term, study finds

After two years of follow up, researchers found no statistical difference in health-related quality of life scores in those who took antidepressants compared with those who did not.…

Published: 21 April 2022

News

Pharmacogenomic testing may be effective in depression treatment, according to study

Patients with major depressive disorder that received treatment guided by pharmacogenomic testing had better outcomes than those who received treatment as usual in the GAP-MDD trial.…

Published: 11 April 2022

Opinion

Why pairing up with a psychologist helped to reduce risky opioid prescribing

Pharmacist Lis Farquhar has found that working with psychologist Vivienne Laidler has allowed them to better approach their patients' reliance on opioids.…

Published: 11 April 2022

Opinion

A digital approach to improving valproate safety

The development of a virtual dashboard in Surrey has made it possible to identify women taking valproate who are approaching their annual review and highlight those who may need to see their GP.…

Published: 6 April 2022

News

More than 1,000 patients stopped taking antidepressants after introduction of local deprescribing guidelines

Exclusive: Guidelines published in 2021 have helped Sunderland Clinical Commissioning Group move from having the fifth highest antidepressant prescribing rate in the country to the eighth highest.…

Published: 28 March 2022

News

Therapy combined with MDMA is effective in treating severe PTSD, phase III trial results suggest

Researchers concluded that MDMA-assisted therapy was highly efficacious, safe and well tolerated in those suffering from severe post-traumatic stress disorder.…

Published: 22 March 2022

News

Antipsychotics increasingly prescribed for personality disorders, against NICE guidance

Study results have shown that antipsychotics have been prescribed for personality disorders more often and for longer periods of time between 2000 and 2016.…

Published: 15 March 2022

News

Community mental health pharmacist training scheme to start in April 2022

Exclusive: The University of Bradford will begin year-long training of 50 pharmacists to become specialist mental health pharmacists in April 2022.…

Published: 7 March 2022